137 related articles for article (PubMed ID: 28546106)
1. Enhanced dissolution and skin permeation profiles of epalrestat with β-cyclodextrin derivatives using a cogrinding method.
Furuishi T; Takahashi S; Ogawa N; Gunji M; Nagase H; Suzuki T; Endo T; Ueda H; Yonemochi E; Tomono K
Eur J Pharm Sci; 2017 Aug; 106():79-86. PubMed ID: 28546106
[TBL] [Abstract][Full Text] [Related]
2. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
Jain SK; Gupta Y; Jain A; Amin S
Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
[TBL] [Abstract][Full Text] [Related]
3. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Oral Bioavailability of Epalrestat SBE
Alvi Z; Akhtar M; Mahmood A; Ur-Rahman N; Nazir I; Sadaquat H; Ijaz M; Syed SK; Waqas MK; Wang Y
Int J Nanomedicine; 2021; 16():8353-8373. PubMed ID: 35002232
[TBL] [Abstract][Full Text] [Related]
6. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression.
Banala VT; Urandur S; Sharma S; Sharma M; Shukla RP; Marwaha D; Gautam S; Dwivedi M; Mishra PR
Biomater Sci; 2019 Jun; 7(7):2889-2906. PubMed ID: 31086900
[TBL] [Abstract][Full Text] [Related]
7. Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.
Felton LA; Wiley CJ; Godwin DA
Drug Dev Ind Pharm; 2002 Oct; 28(9):1117-24. PubMed ID: 12455470
[TBL] [Abstract][Full Text] [Related]
8. The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.
Li J; Jiang Q; Deng P; Chen Q; Yu M; Shang J; Li W
J Pharm Pharmacol; 2017 Jun; 69(6):663-674. PubMed ID: 28299800
[TBL] [Abstract][Full Text] [Related]
9. Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
Senthilkumari S; Sharmila R; Chidambaranathan G; Vanniarajan A
J Ocul Pharmacol Ther; 2017; 33(1):34-41. PubMed ID: 27835059
[TBL] [Abstract][Full Text] [Related]
10. Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin.
Mura P; Bragagni M; Mennini N; Cirri M; Maestrelli F
Int J Pharm; 2014 Nov; 475(1-2):306-14. PubMed ID: 25194352
[TBL] [Abstract][Full Text] [Related]
11. Effect of pH and complexation on transdermal permeation of gliquidone.
Sridevi S; Diwan PV
Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452
[TBL] [Abstract][Full Text] [Related]
12. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
Mennini N; Bragagni M; Maestrelli F; Mura P
J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of mechanochemical treatment with cyclodextrins on increasing solubility of glimepiride.
Iwata M; Fukami T; Kawashima D; Sakai M; Furuishi T; Suzuki T; Tomono K; Ueda H
Pharmazie; 2009 Jun; 64(6):390-4. PubMed ID: 19618676
[TBL] [Abstract][Full Text] [Related]
14. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of binary and ternary complexes of diclofenac with a methyl-beta-CD and monoethanolamine and in vitro transdermal evaluation.
Mora MJ; Longhi MR; Granero GE
Eur J Med Chem; 2010 Sep; 45(9):4079-88. PubMed ID: 20566230
[TBL] [Abstract][Full Text] [Related]
16. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
17. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
18. Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and l-arginine aimed to improve the drug solubility.
Mennini N; Maestrelli F; Cirri M; Mura P
J Pharm Biomed Anal; 2016 Sep; 129():350-358. PubMed ID: 27454086
[TBL] [Abstract][Full Text] [Related]
19. Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin.
Babu RJ; Pandit JK
Int J Pharm; 2004 Mar; 271(1-2):155-65. PubMed ID: 15129982
[TBL] [Abstract][Full Text] [Related]
20. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
